DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
GMED logo

Globus Medical, Inc. Stock Price

NYSE:GMED Community·US$10.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 56 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

GMED Share Price Performance

US$73.56
13.94 (23.38%)
​
US$103.23
Fair Value
US$73.56
13.94 (23.38%)
28.7% undervalued intrinsic discount
US$103.23
Fair Value
Price US$73.56
AnalystConsensusTarget US$103.23
AnalystLowTarget US$84.00
AnalystHighTarget US$123.00
Wed, 12 Aug 26
Fair ValueUS$103.23
Share Pricen/a

GMED Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$103.23 28.7% undervalued intrinsic discount

Spine Procedure Trends And Robotics Will Shape Industry Position Amid Margin Pressures

0users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$84 12.4% undervalued intrinsic discount

Integration And Supply Risks Will Curb Margins Yet Unlock Value

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$123 40.2% undervalued intrinsic discount

Aging Demographics And Digital Trends Will Transform Orthopedic Care

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
GMED logo
Globus Medical
12.4% undervalued intrinsic discount

Integration And Supply Risks Will Curb Margins Yet Unlock Value

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 26 Aug
Read Narrative
GMED logo
Globus Medical
28.7% undervalued intrinsic discount

Spine Procedure Trends And Robotics Will Shape Industry Position Amid Margin Pressures

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 12 Aug
Read Narrative
GMED logo
Globus Medical
40.2% undervalued intrinsic discount

Aging Demographics And Digital Trends Will Transform Orthopedic Care

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 27 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
GMED logo

GMED: Earnings Power And Integration Progress Will Test Capital Spending Concerns

Fair Value: US$84 12.4% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
GMED logo

GMED: Future Returns Will Reflect Margin Expansion From Integrated Platform Synergies

Fair Value: US$103.23 28.7% undervalued intrinsic discount
19 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
GMED logo

GMED: Margin Expansion And EBITDA Execution Will Drive Future Repricing Potential

Fair Value: US$123 40.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued with flawless balance sheet.

0 Risks
5 Rewards
View Full Analysis

Globus Medical, Inc. Key Details

US$3.1b

Revenue

US$975.7m

Cost of Revenue

US$2.2b

Gross Profit

US$1.6b

Other Expenses

US$535.4m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.99
68.98%
17.03%
0%
View Full Analysis

About GMED

Founded
2003
Employees
6000
CEO
Keith Pfeil
WebsiteView website
www.globusmedical.com

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Recent GMED News & Updates

Recent updates

No updates

Globus Medical, Inc. Competitors

CI logo

Cigna Group

Symbol: NYSE:CI
Market cap: US$73.5b
BSX logo

Boston Scientific

Symbol: NYSE:BSX
Market cap: US$65.2b
COR logo

Cencora

Symbol: NYSE:COR
Market cap: US$61.7b
CAH logo

Cardinal Health

Symbol: NYSE:CAH
Market cap: US$55.8b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide